Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunpoong Bio is a South Korean biotechnology company specializing in the development and manufacture of high-quality marine-derived functional ingredients. Founded in 1993, the company is a global leader in the production of chitosan, glucosamine, and chito-oligosaccharides derived from crustacean shells. Their products serve the pharmaceutical, nutraceutical, and cosmetic industries, with a primary focus on joint health and immune system support. Kunpoong Bio operates advanced manufacturing facilities, including a major plant on Jeju Island, and maintains international quality certifications such as EU GMP, ISO, and Halal. The company is recognized for its technological expertise in enzymatic hydrolysis and high-purity extraction processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunpoong Bio.